chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was afraid to get COVID vaccine but was being mandated by his place of employment.  As soon as the vaccine was given, the patient fainted.  He came to a few seconds later but was complaining of being hot and nauseous.  He also was very tense.  His hands and thumbs became very rigid and he was unable to open his fingers.  He was beginning to panic and had a difficult time talking.  We asked a provider in our office to check him out and make sure he was ok.  The provider thought it was best to send him to the hospital to be evaluated.
Started taking Bactrim on 2/18/21 (5 days after vaccination) for hydradenitis suppurativa. Suffered a Stevens Johnson syndrome reaction on 2/20/21. Has been taking Bactrim for years for this condition. We are reporting this in case it was the vaccine that triggered her immune system to react to the Bactrim.
stomach problems; couldn't eat; It's hard to open up, and then it hurts; It's hard to open up, and then it hurts; feels "grabbing in my right side, the cancer is getting bigger"; "my mind is going on me",; has trouble remembering things; joint pain comes and goes; unable to get out of bed for 2 or 3 days; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): EC-2021-098111 (RA).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation; lenvatinib mesilate (LENVIMA), oral, administration date 31Jul2021 (Lot number: 1391898) as 8 mg, daily for hepatic cancer. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: GASTRIC DISORDER (non-serious), outcome "unknown", described as "stomach problems"; APPETITE DISORDER (non-serious), outcome "unknown", described as "couldn't eat"; DEPRESSED MOOD (non-serious), PAIN (non-serious), outcome "unknown" and all described as "It's hard to open up, and then it hurts"; THINKING ABNORMAL (non-serious), outcome "unknown", described as "feels "grabbing in my right side, the cancer is getting bigger"; "my mind is going on me","; MEMORY IMPAIRMENT (non-serious), outcome "unknown", described as "has trouble remembering things"; ARTHRALGIA (non-serious), outcome "unknown", described as "joint pain comes and goes"; BEDRIDDEN (non-serious), outcome "unknown", described as "unable to get out of bed for 2 or 3 days". The action taken for lenvatinib mesilate was unknown.  Additional information: Was the event considered a drug interaction: No, Was dose of the product reduced due to event: No, Was the product discontinued due to event: No. Clinical Course: Patient reported "joint pain comes and goes, I'm fine right now. Sometimes I can't even roll out of bed"; missed appointments due to being "unable to get out of bed for 2 or 3 days"; unable to bend left pointer finger. "It's hard to open up, and then it hurts"; "stomach problems after getting the COVID shot, couldn't eat, would throw it back up, better now"; feels "grabbing in my right side, the cancer is getting bigger"; "my mind is going on me", has trouble remembering things.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient developed hives over the body and a fever of 102.  He experienced tiredness and flu-like symptoms.   PAtient went to the doctor and recieved prednisone and zantac to treat. he lso took benadryl.   He wasreportedly doing better today  (6-9-2019)
Vomiting 2 days after shots for 4-6wks has happened after each set of shots. This is the 3rd episode.
Patient states still having injection site pain but is improving also states having problems lifting arm above head and has trouble at times holding a pot in her left hand.
I had fatigue, severe weakness, faint, dizzy, headache, Myalgia(possible neuropathy) from 3 days out to 2 weeks for these symptoms. Jaw pain, sore and itchy shingles.
pt devel fever; bulging fontanel; paralysis & numbness of rt leg;cold hands/feet; poor feeding; fussy/listless; hosp; unspecified cultures revealed viral infect; disch; mom states residual damage to rt leg; walks/runs w/limp;
Post vaccination, patient tried to stand up and had a fall. Patient was conscious not requiring any treatment. Ambulance was called but the service was not needed. Patient was accompanied by his father
Patient was super hyper for hours after the vaccine.  he is normally energetic, but he was jumping and bouncing, not listening - even fell out of his chair at dinner multiple times because of his inability to stop moving.  at bedtime, he thrashed for hours before he finally settled down enough to go to sleep - and continued to jerk and thrash for a couple hours after he was asleep.   not seizure, just like he had so much energy he couldn't get rid of it.    day was otherwise normal, outside play time, no new foods.  bedtime was later than normal and with resistance.
circular inflammation, itching on the 9th day after injection at the injection site.  Not severe, just the timing seems odd . I was under the impression that this could happen the first few days after injection.  No fever or intense pain.  Hopefully nothing further to report
Pfizer / BioNTech / Paxlovid treatment; Pfizer / BioNTech / Paxlovid treatment; This is a spontaneous report received from a contactable Consumer. The reporter is the patient. A 57-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 02May2022 as dose 4 (booster), single (Lot number: FP4554) at the age of 57 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Mitral valve prolapse" (unspecified if ongoing). There were no concomitant medications. It was reported that patient received Paxlovid from 17Aug2022 to 23Aug2022 for COVID-19 treatment. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Outcome of the events was not recovered.
This spontaneous report was received from a healthcare worker (also reported as office manager) refers to multiple unspecified patients of unknown demographics. No relevant medical history of the patients was reported. On unspecified dates the multiple unspecified patients were vaccinated with (Oka/Merck) VARIVAX (strength, dose, route, site of administration and lot number were not reported). There were no concomitant medications reported. It was reported that the multiple unspecified patients were administered with (Oka/Merck) VARIVAX that was stored improperly on unknown dates. There were not adverse effects reported.  It was unspecified wether the patients had sought any medical attention. There was no product quality complaint involved.   Follow up information has been received from office manager, who stated she may call or fax information as it become available. Also reported that M-M-R II was not mentioned in the original call, but did experience a temperature excursion. No further information was available at that time.  Follow-up information as received from a healthcare professional refers to a 19 months old patient. On 03-JUN-2014 the patient was vaccinated with a dose of improperly stored M-M-R II (lot # reported as J011332, expiration date 13-SEP-2015) (strength, dose, route and site of administration were not reported).  This is one of several reports from the same reporter. Additional information has been requested.
Approximately 1-2 weeks after the first dose, pt began having intermittent brief episodes of his heart "pounding."  Not tachycardia, just pounding, at most for 3 beats.  NO associated symptoms.  No lightheadedness, syncope, SOB, CP, or other Sx.  Normal exercise tolerance; no other illness.  EKG showed intermittent right bundle branch block.  The pt's symptoms have improved spontaneously & are not related to the intermittent RBBB.  All other labs & testing were normal (see below); no Tx.
PATIENT  CAME IN PHARMACY , SHOWING RED PATCHES ON HER LEFT ARM.  SHE SAID IT STARTED ON 01/25/2021.  THE RED PATCHES WERE ITCHING AND FELT WARM , ACCORDING TO PATIENT. PATIENT SAID SHE CONTACTED VAERS AND WERE TOLD THAT IT WAS NORMAL TO HAVE THAT REACTION AND IT WAS OKAY TO GET SECOND DOSE.
swollen site of injection, red about 3cm by day 3, bigger by day 7. Hot to the touch and very painful
Pt. felt lightheaded about 8 minutes later after vaccines were received (varicella #2 and a TB test), when she was back out in the front office paying. She fainted out of her chair. We kept her lying on the ground and she was concious quickly, but disoriented and didn't realize she fainted. The mucosal membranes of her eyes were reddened for about 5 minutes then cleared up. She was alert and oriented x3 within a couple of minutes, was given juice and crackers and BP taken right away, which was 108/70. She stated she normally runs around 128/80. She stated some nausea. She was moved to a couch to rest. Continuous BP's were 98/64, 96/72, 90/70. Pt. had a previous Varicella at an earlier age with no reaction. She is allergic to sulfa meds and stated a previous sensitivity to anesthesia in the past. Pt. rested for about 70 minutes before leaving with her mother. Was taken to the doctor for evaluation right after leaving our facility. BP was still in 90's over 70 and she still stated nausea. The physician she saw requested and received an ingredient list from us for the vaccine and TB solution.
Bexsero/given on 05May2021 and Covid vaccine (unknown) on 01May2021; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate schedule of vaccine administered in a 16-year-old male patient who received Men B NVS (Bexsero) (batch number ABXB28AA, expiry date 30th June 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis and COVID 19 VACCINE for prophylaxis.   On 5th May 2021, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 1st May 2021, the patient received COVID 19 VACCINE. On 5th May 2021, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced inappropriate schedule of vaccine administered. On an unknown date, the outcome of the inappropriate schedule of vaccine administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional information was provided as follow: The patient received a dose of Bexsero vaccine, 4 days after having Covid Vaccine (unknown) on 1st May 2021, which led to inappropriate schedule of vaccine administration. As per CDC (Center for Disease Control and Prevention ) recommendations, Bexsero was given in less than 14 days in  between with a Covid vaccine. The reporter consented to follow up by email. No address provided by reporter.
FAINTED; This spontaneous report received from a patient concerned a 53 year old male of unknown race and ethnicity. The patient's weight was 100 kilograms, and height was not reported. The patient's concurrent conditions included: secondary pulmonary hypertension. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry: Unknown) dose was not reported, 1 total, administered on 02-AUG-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Concomitant medications included tadalafil. On 17-AUG-2021, the patient fainted after taking the dog outside which might have been heat related. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of fainted was not reported. This report was serious (Other Medically Important Condition). This case, involving the same patient is linked to A-NJ2020-205487.; Sender's Comments: V0:20210849338-COVID-19 VACCINE AD26.COV2.S-Fainted. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
81-year-old female with past medical history of hypertension, chronic respiratory failure on 2 L oxygen at night, asthma, depression, anxiety, atrial fibrillation, coronary artery disease, who presented to the hospital complaining of a shortness of breath.  The patient reported that she was vaccinated for a COVID-19 couple months ago 2nd shot, again presented to the hospital for a shortness of breath getting worse for the last 2 days.  The patient has been in contact with and exposed to a positive COVID person, her husband, and he is in the ICU.  Vitals were T-max 98.6, heart rate tachycardic, tachypneic, and blood pressure 150/100.  The patient had a chest x-ray, which showed a congestion as well as right perihilar infiltrate.  Patient was in the ER on BiPAP.  She denied any headache.  No dizziness.  No blurry vision.  No difficulty swallowing or difficulty hearing.  No chest pain.  Reported shortness of breath with some chills.  No fever.  She denied abdominal pain.  No nausea or vomiting.  No change in bowel habits or urination habits. Diagnosed with COVID on 5/3/2021 prior to admission.
Information has been received from a nurse concerning two adolescent patients with unspecified drug reactions/allergies and unspecified medical history, who on an unspecified dates were vaccinated SQ with 0.5 ml doses of VARIVAX (Merck) (dose unspecified, lot number: 662578/0048Y). Subsequently, these two patients recently complained of pain at the injection site (date unspecified) bad enough for them to seek medical attention at the doctor's office. It was unspecified if lab studies were performed. At the time of the report the patients recovered on unspecified date. No further information has been requested.
Dizziness, sweating, itching from hives, occurred within 30 minutes. ER overnight stay. Was given epinephrine, ZOFRAN.
aches and pains; This is a spontaneous report received from contactable consumer (patient). A female patient of an unspecified age received pneumococcal 13-valent conjugate vaccine (diphtheria CRM 197 Protein) (PREVNAR 13), via an unspecified route of administration in 2015 (batch/lot number was not reported) as single dose for immunization.  The patient's medical history and concomitant medications were not reported. The patient informed that six years ago (unspecified date), she got the pneumonia shot and had aches and pains but it went away for 3 days (revcovered).   No follow-up attempts are needed, information about lot/batch number cannot be obtained.
This spontaneous report was received from a consumer's mother referring to her 25 years old female daughter with no pertinent medical history or drug reactions or allergies. In April 2012 the patient was vaccinated with the first dose of GARDASIL (lot number and expiration date not reported) (dose and route not specified). No other suspect therapies were reported, there was no concomitant medications. The reporter stated that the patient fainted within minutes of getting her first dose of GARDASIL. It was reported that the patient recovered on an unspecified date. No treatment was given for the event. No laboratory diagnostic studies were performed. It was reported that the patient sought medical attention by seeing a doctor. Additional information is not expected.
pale, hyporesponsive state x 30-45mins;onset 4hrs p/vax
I'm having difficulty breathing; My nose is very stuffy; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (I'm having difficulty breathing) and NASAL CONGESTION (My nose is very stuffy) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Concurrent medical conditions included COPD (Patient on oxygen for COPD from 10 months.), Blood pressure high, Diabetes, Gout, Restless leg syndrome and Neuropathy. Concomitant products included OXYGEN for COPD, OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]) for an unknown indication.    On 15-Mar-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced DYSPNOEA (I'm having difficulty breathing) and NASAL CONGESTION (My nose is very stuffy). The patient was treated with SODIUM CHLORIDE (SALINE SPRAY) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (I'm having difficulty breathing) had resolved and NASAL CONGESTION (My nose is very stuffy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's concomitant medications included unspecified medications for Blood pressure, Diabetes, Gout, Restless leg syndrome and Neuropathy. Stuffy nose was very common for the patient.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Form was added and outcome of an Event was updated
Pt received pfizer as 2nd dose instead of Moderna. Pt receved Moderna for 1st dose.
My arm, shoulder and neck on the left side, which is where I had my vaccine, have been very tight and very painful so much that I have trouble turning my head to the left.   I did get very ill a day after the vaccine with fever and aches  and a sore throat for about a day and a half .  My shoulder and neck had a burning pain  with stiffness, which continues to this day.  I try to stretch it out but it keeps coming back.  I kept waking up with a fluey feeling that seemed to get  better as the day went on and it continued, until just recently, as it seemed it got less and less severe as the days went on.
pt recvd vax;48 hrs later, pt devel a local rxn described as "cellulitis" manifested by erythema, heat & swelling;tx w/ IV Ancef & po Keflex;rxn resolved w/in several days;
She got her vaccine, didn't have any problems for the first 3 days.  Then on Thursday she started having some swelling in her left ankle  Friday night she felt a little different, a little off, could not sleep and could not tell what the issue was.  On Saturday night she did an EKG on her apple watch and it was all over the place and it told her that she was in A-fib and her heart rate was 164.   She called her daughter who was downstairs and told her what was wrong, her color was really bad, and she told her that she had such pain in her chest, but it was letting up a bit and that it felt like somebody was sitting on her chest.  They did another EKG and hear rate which was down to 152, and the EKG showed squiggly line and very close together.   She is a retired nurse.  She asked if she wanted to go to the hospital and she decided to wait and see if it was better as the pressure was not as bad.  Her son-in-law is a doctor who informed them to get her dressed and take her to the hospital.  She went to the ER and when she got there she her heart rate was between 150-162, they gave her a Digitalis and put her on a drip of that as well.   They hoped that within a few hours to a day that it would come down, but she still had the drip on Monday, and did let her go home on Monday.  They were talking about doing a Cardioversion and it would be another doctor that was not her doctor, so they agreed and discharged her home.   She had an ablation and saw her Cardiologist, this was on 2/8/22 after her first COVID vaccine, she was in Atrial fibrillation and her rate was 179, 162, did go down to 117 on 2/9/22  She saw Dr. on 2/14/22 and had the ablation on 2/28/22 and had a cardioversion following that.  She went into A-fib several different times, after the 1st and 2nd vaccines and kept watching for it and then when she had the 1st booster in October of 2021  things got bad, and had this vaccine and now they want to possibly do another cardioversion and a pacemaker.    She was in the Hospital for 2 days.
Patient admitted to Medical Center on 7/21/21 with COVID-19 and new onset a fib. Pt was treated for pneumonia two weeks prior with only mild improvement in respiratory symptoms. Patient has had persistent dry cough, weakness, dyspnea on exertion relieved with rest, headache and dizziness.Denies fever, chills, orthopnea, PND, loss of taste/appetite, loss of interest, myalgia, palpitations, abdominal pain, bowel or urinary symptoms or diaphoresis. Pt tested positive for COVID-19 on 7/21/21. Patient was treated with full anticoagulation, dexamethasone, vitamin c, zinc, vitamin d3.  Discharged to home on 7/23/21.
Fever, hives, congestion, runny nose, lethargy, facial swelling, generalized edema. Treated with Benadryl and Pediacare. Symptoms persisted for three days.
Nasal congestion, irritable, fussy, not sleeping, emesis, some diarrhea
Shingles-like pain and itching/Itching beginning behind the knee/then down to the ankle/then to the top of thigh/ moving to the lower back; Pain moving to the lower back; Pain beginning behind the knee/then down to the ankles; Nausea; Arm pain/Pain to the top of thigh; This case was reported by a consumer via call center representative and described the occurrence of pruritus in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included valley fever and shingles.   On 30th August 2020, the patient received the 1st dose of Shingrix (intramuscular). On 31st August 2020, 1 days after receiving Shingrix, the patient experienced pain in arm. On 11th September 2020, the patient experienced pruritus, low back pain, knee pain and nausea. On an unknown date, the outcome of the pruritus, low back pain, knee pain, nausea and pain in arm were recovered/resolved.   It was unknown if the reporter considered the pruritus, low back pain, knee pain, nausea and pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient had received the first dose and twelve days later, the patient experienced shingles-like pain and itching beginning behind the knee, then down to the ankles, then to the top of thigh, then moving to the lower back and the symptoms had resolved. The patient had also experienced nausea and arm pain, which had also resolved. The reporter did not consent to follow-up.
Lt arm started hurting 2 hrs after getting shot.  Pt states pain scale was 7.  States hot and swollen. Pain with movement.  Headache, nausea, vomiting.  Eyesight blurry. Ringing in ears.  Pt felt cold, then hot. Had fever. Went to ER. Stayed in ER for 1 hr
rash; This is a spontaneous report from contactable Physician via Pfizer Sales Representative.  A patient of unspecified age and gender received pneumococcal 13-val conjugate vaccine (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at single dose for immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced rash for 10 days (non-serious) on an unspecified date. Patient visited a physician for concern over rash. The outcome of the event was unknown.    No follow-up attempts are possible. No further information is expected. Information about batch number cannot be obtained.
Patient experienced numbness and tingling in throat.Onsite EMS was called Patient treated, Left aginst medical advice.
Patient came back a week after receiving vaccinations stating great pain in her arm, unable to lift.  States went to primary doctor who stated vaccine went into joint not muscle causing the pain.
Rash Narrative:  3rd day of rash to chest with no relief from Claritin or Benadryl.  Other Relevant History: